Fundacion Aiken De La Comunitat Valenciana
- Address
- lock Available on a paid plan
Eye Diseases Research
At Fundacion Aiken De La Comunitat Valenciana, the clinical trial portfolio is centered on ophthalmology and eye diseases, with a strong focus on conditions that affect central vision and retinal health. The studies are designed to explore new treatment options and better understand how to slow disease progression in people living with dry age-related macular degeneration.
- Research on Dry Age-Related Macular Degeneration aims to evaluate whether new therapies can help preserve vision and improve outcomes for patients.
- Studies in Geographic Atrophy are examining ways to reduce lesion growth and address advanced retinal damage linked to age-related macular degeneration.
- The trials also assess the safety and effectiveness of emerging treatments intended to offer better disease control than current options.
Overall, the site’s research in Valencia is focused on advancing therapies for progressive retinal disease, with the goal of improving care for adults affected by macular degeneration and related vision loss.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Adarx Pharmaceuticals Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundacion Aiken De La Comunitat Valenciana
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Elamipretide Subcutaneous Injections in Patients with Dry Age-Related Macular Degeneration: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Trial | Stealth Biotherapeutics Inc. | Phase III | Not Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ADX-038 | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.